IVD industry loses battle for 5-year transition as EU regulatory reform plans progress
This article was originally published in SRA
Executive Summary
The in vitro diagnostics industry in the EU was dealt a blow by the European Parliament on 22 October when the top item on its wish list – to be given five years, instead of three, to comply with the new proposed IVD Regulation – was rejected during the plenary vote.